The Food and Drug Administration that we know, love, and on occasion love to hate, may soon be a memory. The winds of change are blowing toward Rockville, and the agency may never be the same.
The Food and Drug Administration that we know, love, and on occasion love to hate, may soon be a memory. The winds of change are blowing toward Rockville, and the agency may never be the same.
The signs are all there. First, Margaret Hamburg, PhD, was appointed FDA Commissioner. The savvy, former New York City Health Commissioner knows politics as well as her way around a budget. During her tenure in New York, she managed to quell two major health crises, one by persuading a financially strapped city council to spend money on health services such as public workers hired to visit neighborhoods and watch patients take their medicines. Her modus operandi is a combination of public calm and reliance on science, two essentials for an agency in dire need of an unflappable hand at the wheel.
The nomination of Kansas governor Kathleen Sebelius as Health and Human Services secretary was the second indicator that FDA is headed for a serious shake-up. Governor Sebelius garnered the national spotlight when she conquered a $1.1 billion budget deficit in her first year in office without raising taxes. During her confirmation hearing, she committed to making FDA a "world-class regulatory agency," and cited the need to "involve industry in making sure that we look at products as they move through the food chain and that there is some collaborative operation to make sure that those supply chains are also very involved in keeping our people safe."
Some would argue that the supply chain is already involved in keeping people safe, but that's another editorial. The point is, as HHS secretary, she will be under substantial pressure to improve the image, if not the safety, of the nation's food supply.
To be frank, the public image of food safety could use a little burnishing. In an epic case of bad timing, the day before Sebelius's confirmation hearings, Setton Pistachio (Terra Bella, CA) announced a voluntary recall of approximately 1 million lb of pistachios because of possible salmonella contamination. The pistachios were sold to other companies as ingredients, triggering a chain reaction of recalls from Kraft, Frito-Lay, Whole Foods, Publix, and many other companies.
One solution expressed during the hearings and heard around Washington was to sunder foods from drugs. Governor Sebelius said that it was too soon to talk about splitting FDA's food and drug safety responsibilities into two agencies as some critics have suggested, but the idea was not dismissed so easily. One day after the pistachio incident, the White House announced the creation of a food safety panel chaired by Sebelius and newly minted agriculture secretary Tom Vilsack. The USDA could assume some of FDA's prevention duties, said Vilsack, giving FDA more time for containment and damage control. Other officials pointed to FDA's slim budget and broad mandate as reasons to try something new.
If a reconfigured FDA seems nothing more than Washington hot air, consider what would happen if Congress passed H.R. 1256, which the House approved by a 2:1 margin early in April. The Family Smoking and Tobacco Control Act gives FDA power to regulate tobacco. The bill has limits-FDA can't ban tobacco products outright or set nicotine levels at zero-but allows the agency to regulate how tobacco products are advertised, flavored, and labeled, and requires premarket approval for all new products. If the bill survives the Senate, and if the president signs it into law, FDA will have two years to promulgate new tobacco regulations, a daunting task for its overworked staff.
Meanwhile, one more recall could mean the difference between FDA as it is, and an FDA divided into more manageable pieces. In the event of another incident, HHS Secretary Sebelius and FDA Commissioner Hamburg surely will want to shore up the nation's food safety firewalls. As nominee Sebelius said, inaction is not an option.
James Wagner
Group Publisher
tel: 610/409-9081 begin_of_the_skype_highlighting 610/409-9081 end_of_the_skype_highlighting
fax: 610/409-9082
e-mail: jwagner@nutritionaloutlook.com
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”